BridgeBio Pharma
Price & Volume
Stats
See more52W Range | $60.55-$93.41 |
Market Cap | $14.6B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $945.5M |
Revenue Growth (YoY) | 192.6% |
Gross Profit (12 Mos) | $891.9M |
Diluted EPS | -$3.03 |
News
See moreYahoo Finance • yesterday
BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026
Yahoo Finance • 5 days ago
BridgeBio's Heart Disorder Drug Attruby Faces Unanticipated Near-Term Tailwinds, UBS Says
Yahoo Finance • 6 days ago
BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates
Yahoo Finance • 24 days ago
BridgeBio reports improved symptoms in Phase 3 trial of rare-disease drug
About
CEO | Dr. Neil Kumar Ph.D. |
CFO | Dr. Thomas Trimarchi Ph.D. |
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,081 |